Revised SPC: Rinvoq (upadacitinib) capsules

SPC updated to include psoriatic arthritis and ankylosing spondylitis as additional licensed indications. Acne, bronchitis, herpes zoster, herpes simplex have now been added as common adverse events.

electronic Medicines compendium